 |
| Satellite Dinner Symposium The Managed Care Review Board® - Examining the Impact of Cardiovascular Safety with Emerging Treatments for Type 2 Diabetes |
Jointly provided by Postgraduate Institute for Medicine and Impact Education, LLC.  | This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals/Lilly USA, LLC Alliance, Merck & Co., Inc., and Novo Nordisk, Inc. |
| Wednesday, March 29, 2017 6:00 PM - 8:00 PM Colorado Convention Center Room Mile High 4A-4C Denver, CO Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required. | Held in conjunction with  AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017. |
Click here to download the slides from this symposium. Coming Soon: On-demand CE Activity. Check back in December 2017! |
| HOT TOPICS |
|
| DISTINGUISHED FACULTY PRESENTERS |
 | Jennifer Green, MD Associate Professor of Medicine Duke University Medical Center Division of Endocrinology Chief, Endocrine Section Durham VA Medical Center |  | John Fox, MD, MHA Vice President, Associate Chief Medical Officer Medical Affairs Priority Health |
 | Vanita K. Pindolia, PharmD, BCPS Vice President, Ambulatory Clinical Pharmacy Programs_PCM Henry Ford Health System/Health Alliance Plan of Michigan |  | Curtis Triplitt, PharmD, CDE Texas Diabetes Institute, University Health System Associate Professor of Medicine, Clinical Division of Diabetes University of Texas Health Science Center at San Antonio |
| WHO SHOULD ATTEND? |
| This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017. |
| STATEMENT OF NEED / PROGRAM OVERVIEW |
Prospective epidemiological and experimental studies have reported an association between suboptimal glycemic control as measured by an elevated glycated hemoglobin and both micro- and macrovascular complications. Individuals with type 2 diabetes mellitus (T2DM) have a 3-fold increase in cardiovascular mortality and a 2-fold increase in overall mortality compared to age-matched peers without T2DM. There is a clear need to develop therapeutic strategies to mitigate disease progression as well as reduce the cardiovascular disease burden. Managed care pharmacists and other payer professionals require a thorough understanding of recent and emerging cardiovascular clinical trial evidence that can impact both clinical and economic outcomes for patients with T2DM. This symposium will enable plan decision-makers to more thoroughly evaluate T2DM agents under consideration for formulary inclusion as well as guide development of the plan T2DM benefit design and the T2DM treatment algorithm. The educational format of The Managed Care Review Board® will feature a multi-specialty, multi-professional faculty that collaborate, under the leadership of an Activity Chair, on the review of the clinical data, current guidelines, and economic data of a class of therapeutics. Similar to a mock pharmacy and therapeutics committee format, the program will include time for peer-to-peer discussion and debate among the diverse group of faculty members and the audience. |
| EDUCATIONAL OBJECTIVES |
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
|
| AGENDA |
Date and Time Wednesday, March 29, 2017 6:00 PM - 8:00 PM Colorado Convention Center Room Mile High 4A-4C Denver, CO |
| 6:00 PM | Dinner and Registration |
| 6:10 PM | Pre-Activity Learning Assessment and Opening Comments Vanita K. Pindolia, PharmD, BCPS |
| 6:15 PM | Clinical Benefits Overview - Applying Cardiovascular Outcomes Trials in Type 2 Diabetes to the Managed Care Setting Jennifer Green, MD |
| 6:45 PM | Practice Guidelines Review - Aligning Managed Care T2D Treatment Algorithms with Recent CVOT Trial Data John Fox, MD, MHA |
| 7:10 PM | Benefit Design Considerations - CVOT Results and Plan Benefit Designs: Maximizing Value for Emerging T2D Therapies Vanita K. Pindolia, PharmD, BCPS |
| 7:30 PM | Patient Management - Patient-Centered Strategies to Minimize Cardiovascular Risk in Patients in a Managed Care Setting Curtis Triplitt, PharmD, CDE |
| 7:45 PM | Audience Question and Answer Session Closing Commentary by Activity Leader Post-Test Assessment with Peer Benchmarking |
| 8:00 PM | Adjournment |
| ACCREDITATION INFORMATION |
| Physician Continuing Medical Education This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education |
 | Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - 0809-9999-17-408-L01-P Type of Activity: Knowledge For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. |
| Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CPE/CME activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required. Pre-registration will close at 12:00 pm on March 28, 2017. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net. |